Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere's 2013 Revenues Nearly Double but Loss Widens

NEW YORK (GenomeWeb News) – Nanosphere today said that revenues for full-year 2013 nearly doubled year over year, matching the consensus Wall Street estimate on the top line.

The Northbrook, Ill.-based firm said that it recorded $10.0 million in revenues for the year, up from $5.1 million in 2012. All revenues were derived from product sales, while grant and contract revenues declined to none in 2013 from $44,000 a year ago.

The revenue growth was driven mostly by adoption of the Verigene system and the company's infectious disease tests by US-based microbiology laboratories, it said, adding that there were 161 new customer placements for the year.

Nanosphere's loss for the year totaled $34.7 million, or $.56 per share, compared to a loss of $32.9 million, or $.67 per share, in 2012. It edged out the consensus analyst estimate of a loss of $.57 per share.

It cut its R&D spending 6 percent year over year to $18.6 million from $19.7 million but upped its SG&A costs 27 percent to $18.7 million from $14.7 million.

The company ended 2013 with $41.5 million in cash and cash equivalents.

For full-year 2014, Nanosphere said that it anticipates between $19 million and $21 million in revenues and about 200 new customer placements.

The company also said that its fourth quarter revenues increased to $3.4 million from $1.6 million in the year-ago period. Analysts had, on average, estimated Q4 revenues of $3.5 million. During the quarter, the firm added 35 new customer placements.

Nanosphere's net loss in the quarter increased to $8.8 million from $7.6 million a year ago. It did not release any other financial figures for the fourth quarter.

In morning trading Wednesday on the Nasdaq, Nanosphere's shares were up nearly 12 percent at $2.40.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.